Clementia Pharmaceuticals (CMTA) – Management Comments
-
Ipsen Announces Acquisition of Clementia Pharmaceuticals (CMTA)
-
Clementia (CMTA) Granted Rare Pediatric Disease Designation by FDA for Palovarotene for FOP
-
-
-
-
-
-
-
-
-
-
Back to CMTA Stock Lookup